These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16885749)

  • 1. Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy.
    Mehrotra P; Gonzalez MA; Johnson SJ; Coleman N; Wilson JA; Davies BR; Lennard TW
    Laryngoscope; 2006 Aug; 116(8):1434-8. PubMed ID: 16885749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Ki-67 as a proliferative marker in lesions of thyroid.
    Pujani M; Arora B; Pujani M; Singh SK; Tejwani N
    Indian J Cancer; 2010; 47(3):304-7. PubMed ID: 20587907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
    Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.
    Aiad HA; Bashandy MA; Abdou AG; Zahran AA
    Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance.
    Shomori K; Nishihara K; Tamura T; Tatebe S; Horie Y; Nosaka K; Haruki T; Hamamoto Y; Shiomi T; Nakabayashi M; Ito H
    Gastric Cancer; 2010 Aug; 13(3):177-85. PubMed ID: 20820987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of the MIB-1 proliferative markers in the diagnosis and prognosis of tumors of the thyroid gland].
    Ludvíková M; Ryska A; Hovorková E; Pikner R
    Cesk Patol; 2002 Jan; 38(1):4-10. PubMed ID: 11933461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions.
    Castelblanco E; Zafon C; Maravall J; Gallel P; Martinez M; Capel I; Bella MR; Halperin I; Temprana J; Iglesias C; Puig-Domingo M; Robledo M; Matias-Guiu X; Mauricio D
    Thyroid; 2017 Jan; 27(1):59-66. PubMed ID: 27796194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
    Tan A; Etit D; Bayol U; Altinel D; Tan S
    Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
    Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity.
    Giaginis C; Georgiadou M; Dimakopoulou K; Tsourouflis G; Gatzidou E; Kouraklis G; Theocharis S
    Dig Dis Sci; 2009 Feb; 54(2):282-91. PubMed ID: 18465232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of IMP3, nucleophosmin, and Ki-67 expression in papillary thyroid carcinoma.
    Yorukoglu A; Yalcin N; Avci A; Cakalagaoglu F; Yaylali G; Akin F; Haciyanli M; Ozden A
    Int J Surg Pathol; 2015 Feb; 23(1):5-12. PubMed ID: 25389240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance.
    Tokuyasu N; Shomori K; Nishihara K; Kawaguchi H; Fujioka S; Yamaga K; Ikeguchi M; Ito H
    Gastric Cancer; 2008; 11(1):37-46. PubMed ID: 18373176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor.
    Cui W; Lu X; Zheng S; Ma Y; Liu X; Zhang W
    Clin Lab; 2012; 58(5-6):419-26. PubMed ID: 22783570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
    Wojnar A; Kobierzycki C; Krolicka A; Pula B; Podhorska-Okolow M; Dziegiel P
    Folia Histochem Cytobiol; 2010 Sep; 48(3):442-6. PubMed ID: 21097442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland.
    Rickert D; Mittermayer C; Lindenfelser R; Biesterfeld S
    Anal Quant Cytol Histol; 2000 Jun; 22(3):229-34. PubMed ID: 10872040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD56 expression in benign and malignant thyroid lesions.
    Muthusamy S; Azhar Sha S; Abdullah Suhaimi SN; Kassim N; Mahasin M; Mohd Saleh MF; Md Isa N
    Malays J Pathol; 2018 Aug; 40(2):111-119. PubMed ID: 30173227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
    Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
    J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors.
    Sigstad E; Paus E; Bjøro T; Berner A; Grøholt KK; Jørgensen LH; Sobrinho-Simões M; Holm R; Warren DJ
    Mod Pathol; 2012 Apr; 25(4):537-47. PubMed ID: 22157935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.